Tissue Expanders Market Research, 2031
The global tissue expanders market was valued at $671.5 million in 2021, and is projected to reach $1,180.0 million by 2031, growing at a CAGR of 5.8% from 2022 to 2031. Tissue expanders are pre-shaped balloons made of silicon and filler materials that can be filled with saline using a valve system that is either built into the surface of the expander or remote and connected to the expander by a flexible silastic filling tube (nearly all expanders nowadays have a remote valve). The main benefit of the remote valve and filling tube is that it keeps the injection point far from the balloon, eliminating any potential hazards of balloon puncture during expander inflation. Remote positioning enables placing at a location beneath the skin where it can be felt readily.
Tissue expanders and accessories are intended for temporary subcutaneous or submuscular implantation to develop surgical flaps or additional tissue coverage in a variety of surgical applications. Tissue expanders used in various anatomical locations such as breast, head, neck, calf, and others.
Market Dynamics
Growth of the global tissue expanders market size is majorly driven by rise in number of cosmetic surgeries and increase in awareness among people regarding cosmetic reconstructive surgeries. In addition, minimally invasive surgery is surgery done with the aid of a viewing scope and specially designed surgical instruments. The scope allows the surgeon to perform major surgery through several tiny openings without the need for a large incision. Reconstructive surgeries such as breast reconstruction, scalp reconstructive, oral, and maxillofacial reconstruction and others are minimally invasive surgeries. Rise in the adoption of minimally invasive surgeries is anticipated to drive the demand of tissue expanders. Thus, this factor is anticipated to boost the tissue expanders market growth. For instance, according to American Society of Plastic Surgery, in 2020, it was reported that, approximately 2,314,720 cosmetic procedures were performed in U.S.
Increase in the prevalence of breast cancer is anticipated to drive the demand for tissue expanders. Thus, this factor is anticipated to drive the growth of tissue expander market. Breast cancer is the most common type of cancer in women, and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of tissue expanders. In addition, tissue expanders are the most used model for filling breast implants, and with the rise in breast cancer surgeries, the market is expected to grow. For instance, according to World Health Organization (WHO), in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
In addition, according to Breast Cancer.ORG, in 2022, it was reported that, about 13% (about 1 in 8) of U.S. women are going to develop invasive breast cancer in the course of their life. In addition, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive (in situ) breast cancer. Thus, rise in prevalence of breast cancer among female population is anticipated to drive the demand mastectomy. Moreover, mastectomy is anticipated to boost the demand of tissue expanders for breast reconstruction. Therefore, this factor is anticipated to drive the growth of market.
Rise in the awareness among people regarding visual appearance and increase in demand for aesthetic procedure are anticipated to boost the adoption of minimally invasive surgeries. Thus, this factor is anticipated to fuel the demand for tissue expanders and is anticipated to drive the growth of market. Moreover, rise in awareness among people regarding scalp reconstruction, breast reconstruction, oral and maxillofacial reconstruction and scar repair is anticipated to drive the demand for tissue expanders and boost the market growth.
In addition, change in lifestyle, increase in incidence of burn injury, and rise in technological advancement for tissue expander are anticipated to drive the growth of market.
On the other hand, side effects associated with reconstructive surgeries is anticipated to hamper the growth of the tissue expanders market. For instance, side effects such as skin trauma, device malfunction leading to increased operative time, infection, adverse tissue reaction, pain or discomfort, and others are anticipated to hamper the growth of market. In addition, needle injection may lead to minor bruising, bleeding, or other injury to tissue. Inaccurate reading from port detector may lead to bleeding if injection made at wrong location. Inadequate device sterilization or packaging integrity may lead to infection that may lead to additional surgical procedures. Therefore, these factors are anticipated to have negative impact on the growth of market. In addition, high cost of cosmetic surgeries and devices are anticipated to hamper the growth of market.
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global tissue expanders market. The COVID-19 pandemic has stressed healthcare systems in the world. Reconstructive and aesthetic procedures were profoundly affected by the COVID-19 pandemic. Several aesthetic clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for aesthetic procedures during the pandemic. Tissue expansion are non-emergency procedures significantly hampered revenue of aesthetic companies. According to the European Journal of Plastic surgery, in June 2021, it was reported that the total number of surgeries decreased by 23.5% after the COVID-19 outbreak. Moreover, according to the American Society of Plastic Surgeons, in 2020, it was reported that the total number of breast augmentation procedures decreased by 33% from 2019 to 2020.
Segmental Overview
The tissue expanders market share is segmented into Lesion Site, Product Shape and End User and Region. By lesion site, the market is fragmented into lower extremity, upper extremity, and others. By product shape, the market is classified into rectangular, crescent, round, and others. By application, the market is categorized into breast reconstruction, facial reconstruction, and others. By end user, the market is segregated into hospitals, cosmetic clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By lesion site, the market is classified into lower extremity, upper extremity, and others. The others segment dominated the market in 2021 and is expected to continue this trend during the tissue expanders market forecast period, owing to rise in the demand of tissue expanders for burn repair, scar repair and breast reconstruction.
By product shape, the market is categorized into rectangular, crescent, and round and others. The rectangular segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in the number of product launch and product approval rectangular tissue expander.
By end user, the market is divided into hospitals, cosmetic clinics, and ambulatory surgical centers. The hospitals segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in expenditure by government to develop healthcare infrastructure and increase in number of hospitals and clinics.
North America tissue expanders market size is expected grow during the forecast period owing to rise in awareness among people regarding availability of cosmetic surgery and increase in adoption of cosmetic surgery due to high disposable income. Moreover, rise in number of reconstructive surgeries are anticipated to drive the growth of market. For instance, according to the report shared by, American Society of Plastic Surgeons, in 2020, it was reported that, around 2,314,720 cosmetic surgeries were performed in U.S. In addition, as per the same source, it was reported that, approximately 137,808 breast reconstruction surgeries, 24,391 burn care surgeries, 256,085 maxillofacial surgeries were performed in U.S. in 2020.
Asia-Pacific tissue expanders market is expected to grow in the forecast period owing to increase in the number of cosmetic surgeries such as breast reconstruction, scar repair, maxillofacial reconstruction, and scalp reconstruction. In addition, rise in number of market players who manufactures tissue expanders and increase in number of product launch and product approval for tissue expanders are anticipated to drive the growth of market. Moreover, rise in awareness among the people regarding availability of tissue expanders for cosmetic surgery and increase in number of cosmetic surgery clinics are anticipated to drive the growth of market.
Rise in disposable income among population, social media influence, and increase in number of professionals who perform cosmetic reconstructive surgeries are anticipated to drive the growth of market. Moreover, rise in number of tissue expanders industry and increase in number of product launch and product approvals for the tissue expanders are anticipated to drive the growth of market. In addition, increase in number of adoptions of key strategies such as business expansion, acquisition, partnership, agreement, and others are anticipated to drive the growth of market. Moreover, rise in prevalence of breast cancer cause increase in demand for breast reconstruction surgeries and anticipated to drive demand for tissue expanders. Thus, this factor is attributed to have a positive impact on tissue expanders market. For instance, National Cancer Registry Programme (NCRP) estimates that the number of cancer cases is likely to increase from 13.9 lakh in 2020 to 15.7 lakh by 2025 in India, an increase of nearly 20%.
COMPETITION ANALYSIS
Some of the major companies that operate in the global tissue expanders market include GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Gmb, Establishment Labs, Silimed.
Some examples of product approval in the market
In 2022, GC Aesthetics a medical technology company providing aesthetic and reconstructive solutions, announce the CE approval of the new micro-textured anatomical breast implant LUNA xt. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
Partnership in the market
In July 2022, GC Aesthetics a medical technology company providing aesthetic and reconstructive solutions announced partnership with UMECO GROUP, a leading Korean medical device distributor to focused on aesthetic, beauty, and medical markets. This exclusive partnership ensures women and Plastic Surgeons in Korea, to have access to the broad, reliable, long-term proven safe GC Aesthetics product range, for breast enhancement surgery.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tissue expanders market analysis from 2021 to 2031 to identify the prevailing tissue expanders market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the tissue expanders market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global tissue expanders market trends, key players, market segments, application areas, and market growth strategies.
Tissue Expanders Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 1.2 billion |
 Growth Rate | CAGR of 5.8% |
 Forecast period | 2021 - 2031 |
 Report Pages | 397 |
 By Lesion Site |
|
 By Product Shape |
|
 By End User |
|
 By Region |
|
 Key Market Players | Groupe Sebbin SAS, PMT Corporation, Abbvie Inc, POLYTECH Health & Aesthetics GmbH, Silimed, Johnson & Johnson, GC Aesthetics PLC, Sientra, Inc., Establishment Labs, Guangzhou Wanhe Plastic Materials Co. Ltd |
Analyst Review
Tissue expanders are used for various reconstructive procedures varying from the treatment of congenital defects to the secondary reconstruction of extensive burn scars to aid the body to grow new skin, bone, and other tissue. Increase in the number of product launch and product approvals for tissue expanders is anticipated to drive the growth of market. For instance, in 2022, GC Aesthetics a medical technology company providing aesthetic and reconstructive solutions, announced the CE approval of the new micro-textured anatomical breast implant LUNA xt. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
In addition, rise in the number of adoptions of key strategies such as acquisition, partnership, agreement, and business expansion by market players who manufacture tissue expanders is anticipated to drive the growth of market. For instance, in July 2022, GC Aesthetics, a medical technology company providing aesthetic and reconstructive solutions, announced partnership with UMECO GROUP, a leading Korean medical device distributor to focus on aesthetic, beauty, and medical markets. This exclusive partnership ensures women and Plastic Surgeons in Korea, to have access to the broad, reliable, and long-term proven safe GC Aesthetics® product range for breast enhancement surgery.
The top companies that hold the market share in Global Tissue Expanders market are GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Gmb, Establishment Labs, Silimed.
Asia-Pacific is anticipated to witness lucrative growth during the forecast period, owing to rise in expenditure by government organizations to develop the healthcare sector and increase in awareness regarding minimally invasive procedures.
The key trends in the Global Tissue Expanders market are rise in number of cosmetic surgeries and increase in awareness among people regarding cosmetic reconstructive surgeries
The base year for the report is 2021.
Yes, Global Tissue Expanders companies are profiled in the report
The total market value of Global Tissue Expanders market is $671.5 million in 2021 .
The forecast period in the report is from 2022 to 2032
The market value of Global Tissue Expanders market in 2022 was $709.7 million
Loading Table Of Content...
